Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-02-08 @ 5:59 PM
Study NCT ID:
NCT04954794
Status:
COMPLETED
Last Update Posted:
2024-10-31
First Post:
2021-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-01
First Submit QC Date:
None
Study First Post Date:
2021-07-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-29
Last Update Post Date:
2024-10-31
Last Update Post Date Type:
ACTUAL